Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Joly

Showing results (41-50 of 226) with videos related to

Pageof 23
Sort By:
JAAD Case Reports|January 24, 2019
Linear IgA bullous dermatosis treated with rituximabCamille Pinard, Vivien Hebert, Myriam Lecuyer, et al.
JAAD Case Reports|September 30, 2020
Severe dapsone-induced hypoalbuminemia in a case of mucous membrane pemphigoidJasmine Flament, Lamia Jelti, Catherine Lok, et al.
International Journal of Dermatology|January 25, 2017
Tanning practice, perception, and sunburn among Emirati youthAhmed S Aldhaheri, Hassan Galadari, Muhammed J Hashim, et al.
JAMA Dermatology|December 27, 2013
Prolonged evolution of drug reaction with eosinophilia and systemic symptoms: clinical, virologic, and biological featuresFlorence Tetart, Damien Picard, Baptiste Janela, et al.
Clinical and Experimental Dermatology|September 8, 2023
Prevention of recurrent erythema multiforme with lenalidomide: a case seriesSaskia Ingen-Housz-Oro, Pascal Joly, Willy Kini-Matondo, et al.
Frontiers in Immunology|April 3, 2023
Editorial: Autoimmune blistering diseases, volume IIXiaoguang Li, Giovanni Di Zenzo, Enno Schmidt, et al.
The Journal of Investigative Dermatology|March 2, 2005
Response to: mortality rate of bullous pemphigoid in a US medical centerPascal Joly, Jacques Benichou, Philippe Saiag, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 12, 2024
Long-term real costs of a strategy using rituximab as first-line treatment for patients with moderate-to-severe pemphigus: Evaluation from the French healthcare systemBillal Tedbirt, Hermance De Mulder, Pascal Joly, et al.
Tissue Engineering. Part A|April 24, 2012
The impact of substrate stiffness and mechanical loading on fibroblast-induced scaffold remodelingAnsgar Petersen, Pascal Joly, Camilla Bergmann, et al.
Melanoma Research|April 27, 2019
Simultaneous long-lasting regression of multiple nevi and melanoma metastases after ipilimumab therapyMarthe Plaquevent, Anna Greliak, Camille Pinard, et al.
Pageof 23

Showing results (41-50 of 226) with videos related to

Sort By:
Pageof 23
JAAD Case Reports|January 24, 2019
Linear IgA bullous dermatosis treated with rituximabCamille Pinard, Vivien Hebert, Myriam Lecuyer, et al.
JAAD Case Reports|September 30, 2020
Severe dapsone-induced hypoalbuminemia in a case of mucous membrane pemphigoidJasmine Flament, Lamia Jelti, Catherine Lok, et al.
International Journal of Dermatology|January 25, 2017
Tanning practice, perception, and sunburn among Emirati youthAhmed S Aldhaheri, Hassan Galadari, Muhammed J Hashim, et al.
JAMA Dermatology|December 27, 2013
Prolonged evolution of drug reaction with eosinophilia and systemic symptoms: clinical, virologic, and biological featuresFlorence Tetart, Damien Picard, Baptiste Janela, et al.
Clinical and Experimental Dermatology|September 8, 2023
Prevention of recurrent erythema multiforme with lenalidomide: a case seriesSaskia Ingen-Housz-Oro, Pascal Joly, Willy Kini-Matondo, et al.
Frontiers in Immunology|April 3, 2023
Editorial: Autoimmune blistering diseases, volume IIXiaoguang Li, Giovanni Di Zenzo, Enno Schmidt, et al.
The Journal of Investigative Dermatology|March 2, 2005
Response to: mortality rate of bullous pemphigoid in a US medical centerPascal Joly, Jacques Benichou, Philippe Saiag, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 12, 2024
Long-term real costs of a strategy using rituximab as first-line treatment for patients with moderate-to-severe pemphigus: Evaluation from the French healthcare systemBillal Tedbirt, Hermance De Mulder, Pascal Joly, et al.
Tissue Engineering. Part A|April 24, 2012
The impact of substrate stiffness and mechanical loading on fibroblast-induced scaffold remodelingAnsgar Petersen, Pascal Joly, Camilla Bergmann, et al.
Melanoma Research|April 27, 2019
Simultaneous long-lasting regression of multiple nevi and melanoma metastases after ipilimumab therapyMarthe Plaquevent, Anna Greliak, Camille Pinard, et al.
Pageof 23